The United States Endothelial Dysfunction Market is expected to maintain a dominant position during the forecast period, driven by the country’s high prevalence of cardiovascular diseases, diabetes, obesity, and hypertension. The United States benefits from advanced healthcare infrastructure, robust pharmaceutical research and development activities, and widespread adoption of innovative...